Conditions:   Recurrent Endometrial Cancer;   Solid Tumors
Interventions:   Drug: pembrolizumab;   Drug: Sitravatinib
Sponsors:   Haider Mahdi;   Mirati Therapeutics Inc.
Not yet recruiting